Literature DB >> 24297707

Effect of α, β momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.

Gunasekar Manoharan1, Seema R Jaiswal, Jaipaul Singh.   

Abstract

A multitude of plants have been used extensively for the treatment of cancers throughout the world. The protein, α, β momorcharin has been extracted from the plant Momordica charantia (MC), and it possesses anti-cancer and anti-HIV properties similar to the crude water and methanol soluble extract of the plant. This study investigated the anti-cancer effects and the cellular mechanisms of action of α, β momocharin (200-800 μM) on 1321N1, Gos-3, U87-MG, Sk Mel, Corl-23 and Weri Rb-1 cancer cell lines compared to normal healthy L6 muscle cell line measuring cell viability using MTT assay kit, Caspase-3 and 9 activities, cytochrome c release and intracellular free calcium concentrations [Ca(2+)]i. The results show that α, β momorcharin can evoke significant dose-dependent (P < 0.05; Student's t test) decreases in the viability (increases in cell death) of 1321N1, Gos-3, U87-MG, Sk Mel, Corl-23 and Weri Rb-1 cancer cell lines compared to healthy L6 muscle cell line and untreated glioma cells. α, β momorcharin (800 μM) also evoked significant (P < 0.05) increases in caspase-3 and 9 activities and cytochrome c release. Similarly, α, β momorcharin elicited significant (P < 0.05) time-dependent elevation in [Ca(2+)]i in all five glioma cell lines compared to untreated cells. Together, the results have demonstrated that α, β momorcharin can exert its anti-cancer effect on different cancer cell lines by intracellular processes involving an insult to the mitochondria resulting in cellular calcium over loading, apoptosis, cytochrome release and subsequently, cell death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297707     DOI: 10.1007/s11010-013-1914-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

Review 1.  Ethnobotany and ethnopharmacy--their role for anti-cancer drug development.

Authors:  Michael Heinrich; Paul Bremner
Journal:  Curr Drug Targets       Date:  2006-03       Impact factor: 3.465

2.  [Studies on the active constituents of Momordica charantia L].

Authors:  Z J Zhu; Z C Zhong; Z Y Luo; Z Y Xiao
Journal:  Yao Xue Xue Bao       Date:  1990

3.  Role of mitochondria in Ca(2+) oscillations and shape of Ca(2+) signals in pancreatic acinar cells.

Authors:  C Camello-Almaraz; G M Salido; J A Pariente; P J Camello
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

4.  Effects on the hepatocyte [Ca2+]i oscillator of inhibition of the plasma membrane Ca2+ pump by carboxyeosin or glucagon-(19-29).

Authors:  A K Green; P H Cobbold; C J Dixon
Journal:  Cell Calcium       Date:  1997-08       Impact factor: 6.817

5.  An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.

Authors:  P L Tazzari; D de Totero; A Bolognesi; N Testoni; S Pileri; S Roncella; G Reato; H Stein; M Gobbi; F Stirpe
Journal:  Haematologica       Date:  1999-11       Impact factor: 9.941

6.  Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.

Authors:  S W Tsao; T B Ng; H W Yeung
Journal:  Toxicon       Date:  1990       Impact factor: 3.033

7.  Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis.

Authors:  A Singh; S P Singh; R Bamezai
Journal:  Toxicol Lett       Date:  1998-01-16       Impact factor: 4.372

8.  Action of alpha-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines.

Authors:  T B Ng; W K Liu; S F Sze; H W Yeung
Journal:  Gen Pharmacol       Date:  1994-01

9.  Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.

Authors:  J Welihinda; E H Karunanayake; M H Sheriff; K S Jayasinghe
Journal:  J Ethnopharmacol       Date:  1986-09       Impact factor: 4.360

10.  Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol.

Authors:  Mengen Li; Yiwen Chen; Zhongyu Liu; Fubing Shen; Xiaoxiao Bian; Yanfa Meng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-09       Impact factor: 3.848

View more
  7 in total

Review 1.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

Review 2.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

3.  Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.

Authors:  Moustafa Fathy; Michael Atef Fawzy; Henning Hintzsche; Toshio Nikaido; Thomas Dandekar; Eman M Othman
Journal:  Molecules       Date:  2019-11-03       Impact factor: 4.411

Review 4.  Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy.

Authors:  Subhayan Sur; Ratna B Ray
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

5.  Electrospun PVA/CuONPs/Bitter Gourd Nanofibers with Improved Cytocompatibility and Antibacterial Properties: Application as Antibacterial Wound Dressing.

Authors:  Muhammad Nauman Sarwar; Hina Ghulam Ali; Sana Ullah; Kentaro Yamashita; Aiman Shahbaz; Umair Nisar; Motahira Hashmi; Ick-Soo Kim
Journal:  Polymers (Basel)       Date:  2022-03-27       Impact factor: 4.329

6.  Cytoprotective Role of Omentin Against Oxidative Stress-Induced Vascular Endothelial Cells Injury.

Authors:  Nur Aqilah Binti Kamaruddin; Lai Yen Fong; Jun Jie Tan; Muhammad Nazrul Hakim Abdullah; Manraj Singh Cheema; Fahmi Bin Yakop; Yoke Keong Yong
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

Review 7.  Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties.

Authors:  Jia-Qi Lu; Zhen-Ning Zhu; Yong-Tang Zheng; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2020-03-09       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.